CME Group Inc. (NASDAQ:CME) Shares Bought by Fmr LLC

Fmr LLC grew its position in CME Group Inc. (NASDAQ:CME) by 3.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,108,360 shares of the financial services provider’s stock after purchasing an additional 37,911 shares during the quarter. Fmr LLC’s holdings in CME Group were worth $244,560,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Truvestments Capital LLC acquired a new stake in CME Group in the third quarter valued at $26,000. Y.D. More Investments Ltd purchased a new stake in CME Group during the second quarter worth approximately $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. increased its stake in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC raised its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CME. Bank of America upped their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Thursday, October 24th. Finally, Oppenheimer boosted their price objective on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $224.47.

CME Group Stock Up 0.3 %

Shares of CME Group stock opened at $238.00 on Monday. CME Group Inc. has a one year low of $190.70 and a one year high of $238.97. The company has a market cap of $85.77 billion, a P/E ratio of 25.03, a PEG ratio of 5.49 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a fifty day moving average of $225.55 and a two-hundred day moving average of $211.96.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.25 earnings per share. On average, analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.93%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This represents a 14.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,028 shares of company stock valued at $1,811,681 over the last quarter. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.